Black Diamond Therapeutics, Inc. (BDTX) › Net IncomeBlack Diamond Therapeutics, Inc. (BDTX) — Net IncomeAnnual figures by fiscal year, from SEC filings.2018: -$8.93M2019: -$35.26M2020: -$67.25M2021: -$125.60M2022: -$91.17M2023: -$82.44M2024: -$69.68M2025: $22.37M$22.37M2018Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025$22.37M+132.1%2024-$69.68M+15.5%2023-$82.44M+9.6%2022-$91.17M+27.4%2021-$125.60M-86.7%2020-$67.25M-90.7%2019-$35.26M-294.8%2018-$8.93M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share